A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PDTC / poorly differentiated thyroid carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 152
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PDTC  (>> Co-occurring Abbreviation)
Long Form:   poorly differentiated thyroid carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer. ATC, FTC, MTC, PTC, TERT
2021 Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers. ALK, ATC, DTCs, MMP-8, SNP
2021 Clinicopathological Characteristics and Prognosis of Poorly Differentiated Thyroid Carcinoma Diagnosed According to the Turin Criteria. ETE
2021 Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance? PTC, SNP
2021 Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer. AUCs, DDTC, DTC, ECM, FUSCC, GEO, GSEA, LASSO, NT, PTC, ROC, TDS, WGCNA
2021 Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience. DTC, MTC
2021 Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review. ---
2021 p53 protein expression in synchronously occurring dedifferentiating stages of thyroid cancer in a patient with neurofibromas: A case report. ATC, WDTC
2021 PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study. ATC, PD-L1, TAMs, TILs, TME, TPS
10  2021 Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index. PTC
11  2021 Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC. ETE, MTV, OS, RAI-R, TLG
12  2021 Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants. ATC, DSV, LN, PTC, WDPTC
13  2021 Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer. HR, NLR
14  2021 The role of lymph node status in cancer-specific survival and decision-making of postoperative radiotherapy in poorly differentiated thyroid cancer: a population-based study. C-index, CSS, LN, LNR, MLN, PORT, SEER
15  2021 Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. ATC, DTC, MTC, RAI, TKIs
16  2021 Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma. OC
17  2020 A Japanese Family with DICER1 Syndrome Found in Childhood-Onset Multinodular Goitre. MNG
18  2020 Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis. ETE, FTC, MD, ORs, PRISMA, PTC, RR-DTC
19  2020 Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. ATC, KFTC, KI, PTC, SC
20  2020 Contribution of cytologic examination to diagnosis of poorly differentiated thyroid carcinoma. FNA, N/C, WDTCs
21  2020 Dedifferentiation patterns in DTC: is PDTC an intermediate state between DTC and ATC? ATC, DTC, PTC
22  2020 Distribution and Prognostic Significance of Estrogen Receptor alpha (ERalpha), Estrogen Receptor beta (ERbeta), and Human Epidermal Growth Factor Receptor 2 (HER-2) in Thyroid Carcinoma. ERalpha, ERbeta, FTC, HER2, OS, PTC, TC
23  2020 Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC). BNCT, BPA, HDACi
24  2020 Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients. DSS, OS, TC, Tg
25  2020 Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion. ETV6, FISH, MASC, NGS
26  2020 Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. PTC HGF, WHO
27  2020 Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care center. RAI
28  2020 Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. NGS, WES
29  2020 Poorly differentiated thyroid carcinoma with pleomorphic giant cells-a case report. ATC
30  2020 Poorly differentiated thyroid carcinoma. HPFs, MSKCC criteria
31  2020 Solid variant of papillary thyroid carcinoma: an under-recognized entity. PTC, SVPTC
32  2020 The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile. HCCs, PD-L1, WDFCs
33  2020 Tunicamycin promotes metastasis through upregulating endoplasmic reticulum stress induced GRP78 expression in thyroid carcinoma. ATC, ECM, GO, KEGG, TC
34  2020 [Pathology and molecular profile of differentiated thyroid carcinoma]. DTC, FNB, NIFTP, PTC, WHO
35  2019 Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. ATC, EMT, FTC, PTC
36  2019 Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like. ATCs, NT, PTCs
37  2019 Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers. ATC, CD68, TAMs
38  2019 Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in Mice. ALK, Tg
39  2019 Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter. ---
40  2019 Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer. CT, EGDS, TKIs
41  2019 Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol. DTC, FTC, MAPK, PTC, RAI, RAIR, THW
42  2019 Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma. ATC, PDTC1, PTC, TRP53
43  2019 Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing. ATC, PTC
44  2019 Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects. ---
45  2019 Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference? DTC, OS, PDAs
46  2019 Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. DFS, HPF, WHO
47  2019 The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions. FA, FND, FTC, MTC, PTC, PTC fv, Trop-2, UDTC
48  2019 Therapeutic Delivery of miR-143 Targeting Tumor Metabolism in Poorly Differentiated Thyroid Cancer Xenografts and Efficacy Evaluation Using 18F-FDG MicroPET-CT. HK2
49  2019 Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer. ATC, MKIs, OVs
50  2019 Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation. ATC, FTC, MSI, WGS
51  2018 Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth. TSH
52  2018 An algorithmic approach to overcome diagnostic challenges in FNAC in large-cell poorly differentiated thyroid carcinomas. FNAC, PDTC-LC
53  2018 Atypical Features Resembling Poorly Differentiated Thyroid Carcinoma Presenting Entirely within a Follicular Adenoma. ---
54  2018 Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience. ATC
55  2018 Cytopathology of Solid Variant of Papillary Thyroid Carcinoma: Differential Diagnoses with other Thyroid Tumors. cPTC, INIs, SVPTC
56  2018 Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer. ATC, HDACi, HF, HMGA2, PDTT, RAI-R, RAI-U, TKIs
57  2018 PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma. ICIs, IDO1, PD-L1
58  2018 Poorly differentiated carcinoma of thyroid: Case report of an uncommon entity. ATC, WDTC
59  2018 Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition). AJCC/TNM, ATA, DSS, HR, TC
60  2018 Poorly Differentiated Thyroid Carcinoma Patients with Detectable Thyroglobulin Levels after Initial Treatment Show an Increase in Mortality and Disease Recurrence. DSS, RAI, RFS, Tg
61  2018 Predictive factors of outcome in poorly differentiated thyroid carcinomas. ETE, RFS
62  2018 TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. ETE, FTC, PFS, PTC, TCDFC
63  2018 Thyroglobulin "Nonsecretor" Metastatic Poorly Differentiated Thyroid Carcinoma with Noniodine Concentrating Disease and Aggressive Clinical Course: A Clinical Case Series. Tg
64  2018 Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. APC, FTC, MTC, MTD, PTC, PTMC
65  2017 A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter. ---
66  2017 Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases. ATC, HDAC
67  2017 Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer. ATC, ncRNA
68  2017 EXPRESSION OF MENIN IN THE HUMAN THYROID GLAND. ATC, MTC, OA, OC, PTC
69  2017 FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature. ---
70  2017 Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. ATC, cPTC, HVPTC, NGS, PTC
71  2017 Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer. ATC, DTC, IQR
72  2017 Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up. DSS, NAFCTC, OS
73  2017 Poorly Differentiated Thyroid Carcinoma: 10-Year Experience in a Southeast Asian Population. ATC, WDTC
74  2017 Poorly differentiated thyroid carcinoma: A hospital-based clinicopathological study and review of literature. ---
75  2017 Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer. ---
76  2016 Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma. GTV, IMRT
77  2016 Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. DM, DOD, GET, non-ANA FCDC, TCV-PTC
78  2016 Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma. PTC
79  2016 Effects and Role of Multikinase Inhibitors in Thyroid Cancer. DTC, FGFR, PFS, RAI, TKIs
80  2016 Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. PTC, TME
81  2016 Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. ATC, PDTC-Turin, PTC
82  2016 Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma. ATC, MSKCC
83  2016 Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma. FTC
84  2016 Oncocytic variant of poorly differentiated thyroid carcinoma: "Is diagnosis possible by fine-needle aspiration?" FNAs
85  2016 Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma. ATC, DTC
86  2016 Remarkable response in 2 cases of Advanced Poorly Differentiated Thyroid Carcinoma with liposomal doxorubicin plus cisplatin. CR, CT, PR
87  2016 [Advances in studies of the genes related to thyroid carcinoma]. FTC, FVPTC, mutp53, PTC, TC, UTC
88  2015 Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma. ATC, DTC
89  2015 Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ⁸F-FDG PET Study. BRAF-WT, DTC
90  2015 Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study. DTC, FNAC, MTC
91  2015 Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study. FTC, HR, PFS, PTCs, RAIR, TCs, TKIs
92  2015 Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma. ---
93  2015 Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression. DTC, HDAC3, miRNA, NIS, RAIU
94  2015 Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience. EBRT
95  2015 New approaches to image thyroid cancer cells and microenvironment. RAI, UDTC
96  2015 NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. ---
97  2015 Poorly Differentiated and Undifferentiated Thyroid Carcinomas. UTC
98  2015 Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study. RIT
99  2015 Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing. ATC, NGS
100  2015 The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer. ATC, NLR, WDTC